Subtopic Deep Dive

← Plant Toxicity and Pharmacological Properties

Pyrrolizidine Alkaloids Metabolism
Research Guide

What is Pyrrolizidine Alkaloids Metabolism?

Pyrrolizidine alkaloids metabolism encompasses cytochrome P450-mediated bioactivation of PAs to reactive pyrrole metabolites in liver and extrahepatic tissues, alongside species-specific detoxification pathways.

Research identifies intestinal and hepatic biotransformation of PA N-oxides to toxic pyrroles (Yang et al., 2019, 71 citations). Cytochrome P450 enzymes drive activation, with induction observed in retrorsine-treated rats (Gordon et al., 2000, 45 citations). Over 150 papers document hepatotoxicity mechanisms across species.

Curated Papers

Key Challenges

Why It Matters

Metabolic differences predict human PA hepatotoxicity risks from herbal supplements, as shown in in vitro-in silico models for lasiocarpine and riddelliine (Ning et al., 2019, 48 citations). Insights guide species extrapolation in toxicology, informing dietary supplement safety assessments (Stickel et al., 2000, 153 citations). Flavin-dependent monooxygenases reveal insect detoxification strategies applicable to resistance studies (Sehlmeyer et al., 2010, 71 citations).

Key Research Challenges

Species-Specific Bioactivation

Cytochrome P450 variations cause differential PA pyrrole formation across species, complicating human risk prediction (Ning et al., 2019). In vitro-in silico strategies address inter-species differences but require validation (Ning et al., 2019, 48 citations).

Intestinal N-Oxide Reduction

Gut microbes and enzymes reduce PA N-oxides to toxic alkaloids before hepatic metabolism, amplifying exposure (Yang et al., 2019, 71 citations). This pathway challenges oral toxicity models relying on liver-centric assumptions.

Detoxification Enzyme Variability

Flavin monooxygenases detoxify PAs in insects but vary in mammals, affecting susceptibility (Sehlmeyer et al., 2010, 71 citations). Quantifying extrahepatic contributions remains difficult due to tissue-specific expression.

Essential Papers

Hepatotoxicity of botanicals

Felix Stickel, Gerlinde Egerer, Helmut K. Seitz · 2000 · Public Health Nutrition · 153 citations

Abstract Objective Hepatic impairment resulting from the use of conventional drugs is widely acknowledged, but there is less awareness of the potential hepatotoxicity of herbal preparations and oth...

Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids

Mengbi Yang, Jiang Ma, Jianqing Ruan et al. · 2019 · Archives of Toxicology · 71 citations

Flavin-Dependent Monooxygenases as a Detoxification Mechanism in Insects: New Insights from the Arctiids (Lepidoptera)

Sven Sehlmeyer, Linzhu Wang, Dorothee Langel et al. · 2010 · PLoS ONE · 71 citations

Insects experience a wide array of chemical pressures from plant allelochemicals and pesticides and have developed several effective counterstrategies to cope with such toxins. Among these, cytochr...

Workshop Overview: Hepatotoxicity Assessment for Botanical Dietary Supplements

Kristine L. Willett, Robert A. Roth, Larry Walker · 2004 · Toxicological Sciences · 62 citations

Botanical dietary supplements (herbal products) have flooded the market in the United States over the past decade, and studies show a significant percentage of Americans use them. With increasing f...

Gene expression changes induced by the tumorigenic pyrrolizidine alkaloid riddelliine in liver of Big Blue rats

Nan Mei, Lei Guo, Ruqing Liu et al. · 2007 · BMC Bioinformatics · 56 citations

The alterations in gene expression were directly related to the pathological outcomes reported previously. These results provided further insight into the mechanisms involved in toxicity and carcin...

Use of an in vitro–in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine

Jia Ning, Lu Chen, Marije Strikwold et al. · 2019 · Archives of Toxicology · 48 citations

Lasiocarpine and riddelliine are pyrrolizidine alkaloids (PAs) known to cause liver toxicity. The aim of this study was to predict the inter-species and inter-ethnic human differences in acute live...

Role of Neutrophils in the Synergistic Liver Injury from Monocrotaline and Bacterial Lipopolysaccharide Exposure

Steven B. Yee · 2003 · Toxicological Sciences · 46 citations

Synergistic liver injury develops in Sprague-Dawley rats from administration of a small, noninjurious dose (7.4 x 10(6) EU/kg) of bacterial lipopolysaccharide (LPS) given 4 h after a nontoxic dose ...

Reading Guide

Foundational Papers

Start with Stickel et al. (2000, 153 citations) for hepatotoxicity overview; Sehlmeyer et al. (2010, 71 citations) for detoxification mechanisms; Mei et al. (2007, 56 citations) for gene expression insights.

Recent Advances

Study Yang et al. (2019, 71 citations) on intestinal bioactivation; Ning et al. (2019, 48 citations) for in silico predictions; Wang et al. (2021, 40 citations) on supplement toxicities.

Core Methods

Cytochrome P450 assays (Gordon et al., 2000); physiologically-based kinetic modeling (Ning et al., 2019); flavin monooxygenase profiling (Sehlmeyer et al., 2010).

How PapersFlow Helps You Research Pyrrolizidine Alkaloids Metabolism

Discover & Search

Research Agent uses searchPapers and exaSearch to find PA metabolism papers like 'Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides' (Yang et al., 2019), then citationGraph reveals connections to Stickel et al. (2000) and Ning et al. (2019) clusters.

Analyze & Verify

Analysis Agent applies readPaperContent to extract CYP450 kinetics from Yang et al. (2019), verifies species differences with verifyResponse (CoVe), and runs PythonAnalysis on dose-response data for statistical fits (e.g., Ning et al., 2019). GRADE grading scores evidence strength for bioactivation claims.

Synthesize & Write

Synthesis Agent detects gaps in extrahepatic metabolism via contradiction flagging across Sehlmeyer et al. (2010) and Gordon et al. (2000); Writing Agent uses latexEditText, latexSyncCitations for PA pathway reviews, and latexCompile for publication-ready manuscripts with exportMermaid toxicity diagrams.

Use Cases

"Analyze dose-response curves for riddelliine hepatotoxicity from rat liver gene expression data."

Research Agent → searchPapers → Analysis Agent → readPaperContent (Mei et al., 2007) → runPythonAnalysis (NumPy curve fitting, matplotlib plots) → researcher gets fitted EC50 values and visualizations.

"Compile review on PA N-oxide reduction with citations and pathway figure."

Synthesis Agent → gap detection → Writing Agent → latexEditText (draft text) → latexSyncCitations (Yang et al., 2019) → latexCompile → exportMermaid (bioactivation diagram) → researcher gets PDF manuscript.

"Find code for P450 enzyme simulations in PA metabolism papers."

Research Agent → searchPapers → Code Discovery (paperExtractUrls → paperFindGithubRepo → githubRepoInspect) → researcher gets runnable scripts modeling pyrrole formation kinetics from Ning et al. (2019)-linked repos.

Automated Workflows

Deep Research workflow scans 50+ PA papers via searchPapers → citationGraph, producing structured toxicology reports with GRADE-scored mechanisms from Stickel et al. (2000). DeepScan applies 7-step analysis to Yang et al. (2019), verifying N-oxide reduction with CoVe checkpoints and Python stats. Theorizer generates hypotheses on human CYP variations from Ning et al. (2019) and Sehlmeyer et al. (2010).

Try Doxa for Pyrrolizidine Alkaloids Metabolism Research

Frequently Asked Questions

What defines pyrrolizidine alkaloids metabolism?

Cytochrome P450 bioactivation of PAs to pyrrole metabolites in liver, with species-specific detoxification like flavin monooxygenases (Yang et al., 2019; Sehlmeyer et al., 2010).

What are key methods in PA metabolism research?

In vitro-in silico modeling predicts toxicity (Ning et al., 2019); gene expression profiling reveals mechanisms (Mei et al., 2007); CYP induction assays quantify activation (Gordon et al., 2000).

What are major papers on PA hepatotoxicity?

Stickel et al. (2000, 153 citations) overviews botanicals; Yang et al. (2019, 71 citations) details N-oxide biotransformation; Ning et al. (2019, 48 citations) models inter-species differences.

What open problems exist in PA metabolism?

Inter-ethnic human variations in CYP activity need prediction (Ning et al., 2019); extrahepatic pyrrole formation requires quantification; gut microbiome roles in N-oxide reduction remain underexplored (Yang et al., 2019).